Clinical Trial: Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480837) titled 'Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma' on March 14.

Brief Summary: For patients with newly diagnosed or relapsed/metastatic B-cell non-Hodgkin lymphoma following first-line treatment, peripheral blood samples are collected before treatment and at various treatment time points to monitor circulating tumor DNA (ctDNA), aiming to investigate the correlation between dynamic ctDNA changes and patient prognosis.

Study Start Date: Jan. 01

Study Type: OBSERVATIONAL

Condition: B-Cell Non-Hodgkin Lymphoma

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Cancer Instit...